-
公开(公告)号:US07064119B2
公开(公告)日:2006-06-20
申请号:US10509224
申请日:2003-03-24
申请人: Shigeki Seto , Asao Tanioka , Makoto Ikeda , Shigeru Izawa
发明人: Shigeki Seto , Asao Tanioka , Makoto Ikeda , Shigeru Izawa
IPC分类号: C07D487/04 , A61K31/519 , A61K31/5377 , A61K31/541 , A61P1/02
CPC分类号: C07D487/04
摘要: A novel fused bicyclic pyrimidine derivative or a salt thereof that acts as a tachykinin receptor antagonist and, in particular, as an NK1 receptor antagonist is represented by the following general formula (1): wherein the rings A and B are each a benzene ring having 1 to 3 substituents (any adjacent two of which may be bound to one another to form a ring); the ring C is a nitrogen-containing ring; R is a hydrogen atom, a C1 to C6 alkyl group, a C1 to C6 alkylcarbonyl group, or a C1 to C6 alkylsulfonyl group; m is 1 or 2; and n is 2 or 3.
摘要翻译: 用作速激肽受体拮抗剂,特别是作为NK1受体拮抗剂的新型稠合双环嘧啶衍生物或其盐由以下通式(1)表示:其中环A和B各自为苯环, 1至3个取代基(任何相邻的两个可以彼此结合形成环); 环C是含氮环; R是氢原子,C 1至C 6烷基,C 1 -C 6烷基羰基 基团或C 1至C 6烷基磺酰基; m为1或2; n为2或3。
-
公开(公告)号:US20050159409A1
公开(公告)日:2005-07-21
申请号:US10509224
申请日:2003-03-24
申请人: Shigeki Seto , Asao Tanioka , Shigeru Izawa
发明人: Shigeki Seto , Asao Tanioka , Shigeru Izawa
IPC分类号: A61P1/02 , A61P1/04 , A61P1/08 , A61P11/06 , A61P11/14 , A61P13/00 , A61P19/02 , A61P25/00 , A61P25/04 , A61P25/06 , A61P29/00 , A61P37/08 , A61P39/00 , A61P43/00 , C07D487/04 , A61K31/5513 , A61K31/519 , C07D487/02
CPC分类号: C07D487/04
摘要: A novel fused bicyclic pyrimidine derivative or a salt thereof that acts as a tachykinin receptor antagonist and, in particular, as an NK1 receptor antagonist is represented by the following general formula (1): wherein the rings A and B are each a benzene ring having 1 to 3 substituents (any adjacent two of which may be bound to one another to form a ring); the ring C is a nitrogen-containing ring; R is a hydrogen atom, a C1 to C6 alkyl group, a C1 to C6 alkylcarbonyl group, or a C1 to C6 alkylsulfonyl group; m is 1 or 2; and n is 2 or 3.
摘要翻译: 用作速激肽受体拮抗剂,特别是作为NK1受体拮抗剂的新型稠合双环嘧啶衍生物或其盐由以下通式(1)表示:其中环A和B各自为苯环, 1至3个取代基(任何相邻的两个可以彼此结合形成环); 环C是含氮环; R是氢原子,C 1至C 6烷基,C 1 -C 6烷基羰基 基团或C 1至C 6烷基磺酰基; m为1或2; n为2或3。
-
公开(公告)号:US20050085469A1
公开(公告)日:2005-04-21
申请号:US10501551
申请日:2003-01-15
申请人: Shigeki Seto , Asao Tanioka , Makoto Ikeda , Shigeru Izawa
发明人: Shigeki Seto , Asao Tanioka , Makoto Ikeda , Shigeru Izawa
IPC分类号: A61K31/5365 , A61P1/02 , A61P1/04 , A61P1/08 , A61P11/06 , A61P11/14 , A61P13/00 , A61P13/10 , A61P15/00 , A61P19/02 , A61P25/04 , A61P25/06 , A61P29/00 , A61P43/00 , C07D498/04 , C07D498/02 , A61K31/519 , A61K31/58
CPC分类号: C07D498/04 , A61K31/5365
摘要: A novel fused bicyclic pyrimidine derivative or a salt thereof that acts as a tachykinin receptor antagonist and, in particular, as an NK1 receptor antagonist is represented by the following general formula (1): wherein the rings A and B are each a benzene ring having 1 to 3 substituents (any adjacent two of which may be bound to one another to form a ring); the ring C is a nitrogen-containing ring; m is 1 or 2; and n is 2 or 3.
摘要翻译: 用作速激肽受体拮抗剂,特别是作为NK1受体拮抗剂的新型稠合双环嘧啶衍生物或其盐由以下通式(1)表示:其中环A和B各自为苯环, 1至3个取代基(其中任何相邻的两个可以彼此结合形成环); 环C是含氮环; m为1或2; n为2或3。
-
公开(公告)号:US5786486A
公开(公告)日:1998-07-28
申请号:US849160
申请日:1997-05-13
IPC分类号: C07D519/00 , C07D487/00 , C07C13/465 , C07D209/04 , C07D487/02
CPC分类号: C07D519/00
摘要: Acrylamide derivatives represented by General Formula (1) below: ##STR1## (One specific example of General Formula (1) is methyl (S,S)-3,3'-�3,3'-(1,4-phenylenediacryloyl)!-bis�1-chloromethyl-5-hydroxy-7-triflouromethyl-1, 2,3,6-tetrahydropyrrolo�3,2-e!indole-8-carboxylate.) The acrylamide derivatives represented by General Formula (1) is highly selective to cancer cells, less toxic, and highly active also against solid tumor.
摘要翻译: PCT No.PCT / JP95 / 02413 Sec。 371日期1997年5月13日 102(e)日期1997年5月13日PCT提交1995年11月28日PCT公布。 WO96 / 16965 PCT公开号 日本1996年6月6日由通式(1)表示的丙烯酰胺衍生物:通式(1)(通式(1)的一个具体实例是甲基(S,S)-3,3' - [3,3' - (1,4-亚苯基二甲酰基)] - 双[1-氯甲基-5-羟基-7-三氟甲基-1,2,3,6-四氢吡咯并[3,2-e]吲哚-8-羧酸乙酯。)丙烯酰胺衍生物 由通式(1)表示,对癌细胞具有高度的选择性,毒性低,对实体瘤具有高度的活性。
-
公开(公告)号:US20070254866A1
公开(公告)日:2007-11-01
申请号:US11718000
申请日:2007-03-13
申请人: Oana Cociorva , Bei Li , Katrin Szardenings , Yasumichi Fukuda , Masahiro Nomura , Shigeki Seto , Kazuhiro Yumoto , Kyoko Okada , Ayako Nakamura
发明人: Oana Cociorva , Bei Li , Katrin Szardenings , Yasumichi Fukuda , Masahiro Nomura , Shigeki Seto , Kazuhiro Yumoto , Kyoko Okada , Ayako Nakamura
IPC分类号: A61K31/47 , A61K31/535 , A61K31/553 , A61P19/02 , A61P19/10 , A61P25/16 , A61P25/24 , A61P25/28 , A61P3/10 , A61P31/12 , A61P35/00 , C07D215/02 , C07D265/34 , C07D267/08 , C12N9/99
CPC分类号: C12N9/99 , C07D498/06
摘要: Provided herein are aminoquinolones and pharmaceutically acceptable derivatives thereof. In certain embodiments, provided herein are compounds, compositions and methods for treating, preventing or ameliorating GSK-3 mediated diseases.
摘要翻译: 本文提供氨基喹诺酮及其药学上可接受的衍生物。 在某些实施方案中,本文提供了用于治疗,预防或改善GSK-3介导的疾病的化合物,组合物和方法。
-
公开(公告)号:US08063221B2
公开(公告)日:2011-11-22
申请号:US11718000
申请日:2007-03-13
申请人: Oana Cociorva , Bei Li , Anna Katrin Szardenings , Yasumichi Fukuda , Masahiro Nomura , Shigeki Seto , Kazuhiro Yumoto , Kyoko Okada , Ayako Nakamura
发明人: Oana Cociorva , Bei Li , Anna Katrin Szardenings , Yasumichi Fukuda , Masahiro Nomura , Shigeki Seto , Kazuhiro Yumoto , Kyoko Okada , Ayako Nakamura
IPC分类号: C07D215/00 , A01N43/42 , A61K31/47
CPC分类号: C12N9/99 , C07D498/06
摘要: Provided herein are aminoquinolones and pharmaceutically acceptable derivatives thereof. In certain embodiments, provided herein are compounds, compositions and methods for treating, preventing or ameliorating GSK-3 mediated diseases.
摘要翻译: 本文提供氨基喹诺酮及其药学上可接受的衍生物。 在某些实施方案中,本文提供了用于治疗,预防或改善GSK-3介导的疾病的化合物,组合物和方法。
-
公开(公告)号:US08476261B2
公开(公告)日:2013-07-02
申请号:US12678120
申请日:2008-09-12
申请人: Oana Cociorva , Yasumichi Fukuda , Yasushi Kohno , Bei Li , Kyoko Okada , Ayako Nakamura , Masahiro Nomura , Shigeki Seto , Anna Katrin Szardenings , Kazuhiro Yumoto
发明人: Oana Cociorva , Yasumichi Fukuda , Yasushi Kohno , Bei Li , Kyoko Okada , Ayako Nakamura , Masahiro Nomura , Shigeki Seto , Anna Katrin Szardenings , Kazuhiro Yumoto
IPC分类号: A61K31/5386
CPC分类号: C07D498/06 , A61J1/00 , C07D498/10 , C07D498/20
摘要: Provided herein are spirocyclic aminoquinolones of formula I and compositions containing the compounds. The compounds and compositions provided herein are useful in the prevention, amelioration or treatment of GSK-3 inhibitors mediated diseases. In Formula (I): X1 is O or NR8; A is bond or substituted or unsubstituted C1-C2 alkylene, wherein the substituents when present are selected from one to four Q2 groups; where Q2 is alkyl or haloalkyl; p is 0 or 1; and q is an integer of 0 to 2.
摘要翻译: 本文提供式I的螺环氨基喹诺酮和含有该化合物的组合物。 本文提供的化合物和组合物可用于预防,改善或治疗GSK-3抑制剂介导的疾病。 式(I)中,X 1为O或NR 8; A是键或取代或未取代的C 1 -C 2亚烷基,其中当存在时的取代基选自1至4个Q 2基团; 其中Q2是烷基或卤代烷基; p为0或1; q为0〜2的整数。
-
公开(公告)号:US20110034436A1
公开(公告)日:2011-02-10
申请号:US12678120
申请日:2008-09-12
申请人: Oana Cociorva , Yasumichi Fukuda , Yasushi Kohno , Bei Li , Kyoko Okada , Ayako Nakamura , Masahiro Nomura , Shigeki Seto , Anna Katrin Szardenings , Yumoto Kazuhiro
发明人: Oana Cociorva , Yasumichi Fukuda , Yasushi Kohno , Bei Li , Kyoko Okada , Ayako Nakamura , Masahiro Nomura , Shigeki Seto , Anna Katrin Szardenings , Yumoto Kazuhiro
IPC分类号: A61K31/553 , C07D265/28 , C07D487/10 , A61K31/5386 , A61P25/00 , A61P25/28 , A61P1/00 , A61P25/18 , A61P35/00 , A61P3/10
CPC分类号: C07D498/06 , A61J1/00 , C07D498/10 , C07D498/20
摘要: Provided herein are spirocyclic aminoquinolones of formula I and compositions containing the compounds. The compounds and compositions provided herein are useful in the prevention, amelioration or treatment of GSK-3 inhibitors mediated diseases. In Formula (I): X1 is O or NR8; A is bond or substituted or unsubstituted C1-C2 alkylene, wherein the substituents when present are selected from one to four Q2 groups; where Q2 is alkyl or haloalkyl; p is 0 or 1; and q is an integer of 0 to 2.
摘要翻译: 本文提供式I的螺环氨基喹诺酮和含有该化合物的组合物。 本文提供的化合物和组合物可用于预防,改善或治疗GSK-3抑制剂介导的疾病。 式(I)中,X 1为O或NR 8; A是键或取代或未取代的C 1 -C 2亚烷基,其中当存在时的取代基选自1至4个Q 2基团; 其中Q2是烷基或卤代烷基; p为0或1; q为0〜2的整数。
-
-
-
-
-
-
-